Nuveen’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-7,351
Closed -$184K – 3214
2023
Q1
$184K Sell
7,351
-1,878
-20% -$60.5K ﹤0.01% 2999
2022
Q4
$780K Sell
9,229
-2,150
-19% -$67.7K ﹤0.01% 2773
2022
Q3
$961K Buy
11,379
+258
+2% +$8.9K ﹤0.01% 2771
2022
Q2
$940K Sell
11,121
-417
-4% -$38.2K ﹤0.01% 2811
2022
Q1
$1.23M Buy
11,538
+123
+1% +$13K ﹤0.01% 2728
2021
Q4
$1.47M Sell
11,415
-1,093
-9% -$138K ﹤0.01% 2709
2021
Q3
$1.27M Buy
12,508
+1,094
+10% +$111K ﹤0.01% 2890
2021
Q2
$1.17M Buy
11,414
+6,614
+138% +$1.15M ﹤0.01% 2951
2021
Q1
$883K Buy
4,800
+1,078
+29% +$238K ﹤0.01% 2933
2020
Q4
$1.27M Buy
+3,722
New +$878K ﹤0.01% 2719

Other funds holding LONA

Nuveen's LONA Position: Q2 2023 in Review

Nuveen sold out of LeonaBio Inc (LONA) in Q2 2023, closing a stake of 7,351 shares — an estimated $184K sold.

Nuveen first reported a position in LONA in Q4 2020 and held it in 10 quarters. The position peaked at $1.47M in Q4 2021. 77 funds tracked by Wall St. Rank hold LONA as of Q2 2023.

  • Nuveen reported no remaining LeonaBio Inc position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 7,351 LeonaBio Inc shares in Q2 2023, an estimated $184K.
  • Nuveen first reported a position in LeonaBio Inc in Q4 2020 and held it in 10 quarters.
  • Nuveen's LeonaBio Inc position peaked at $1.47M in Q4 2021.
  • 77 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.